vs
EXACT SCIENCES CORP（EXAS）与IES Holdings, Inc.（IESC）财务数据对比。点击上方公司名可切换其他公司
EXACT SCIENCES CORP的季度营收约是IES Holdings, Inc.的1.0倍（$878.4M vs $871.0M），IES Holdings, Inc.净利率更高（10.5% vs -9.8%，领先20.3%），EXACT SCIENCES CORP同比增速更快（23.1% vs 16.2%），EXACT SCIENCES CORP自由现金流更多（$120.4M vs $-18.9M），过去两年EXACT SCIENCES CORP的营收复合增速更高（17.4% vs 11.1%）
Exact Sciences是总部位于美国威斯康星州麦迪逊的分子诊断企业，专注于早期癌症检测领域。公司核心产品覆盖结直肠癌筛查与预防场景，其中Cologuard是全球首个获批的结直肠癌粪便DNA检测产品，同时还提供其他多种癌症的筛查服务及精准肿瘤检测解决方案。
IES Holdings, Inc.前身为Integrated Electrical Services, Inc.，主营业务为集成电气及技术系统的设计与安装，同时面向数据中心、住宅、商业和工业设施等多元终端市场提供基础设施类产品及相关服务。
EXAS vs IESC — 直观对比
营收规模更大
EXAS
是对方的1.0倍
$871.0M
营收增速更快
EXAS
高出6.9%
16.2%
净利率更高
IESC
高出20.3%
-9.8%
自由现金流更多
EXAS
多$139.3M
$-18.9M
两年增速更快
EXAS
近两年复合增速
11.1%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $878.4M | $871.0M |
| 净利润 | $-86.0M | $91.8M |
| 毛利率 | 70.1% | 25.3% |
| 营业利润率 | -9.4% | 11.2% |
| 净利率 | -9.8% | 10.5% |
| 营收同比 | 23.1% | 16.2% |
| 净利润同比 | 90.1% | 59.1% |
| 每股收益（稀释后） | $-0.45 | $4.51 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EXASIESC
| Q4 25 | $878.4M | $871.0M | ||
| Q3 25 | $850.7M | $897.8M | ||
| Q2 25 | $811.1M | $890.2M | ||
| Q1 25 | $706.8M | $834.0M | ||
| Q4 24 | $713.4M | $749.5M | ||
| Q3 24 | $708.7M | $775.8M | ||
| Q2 24 | $699.3M | $768.4M | ||
| Q1 24 | $637.5M | $705.7M |
净利润EXASIESC
| Q4 25 | $-86.0M | $91.8M | ||
| Q3 25 | $-19.6M | $102.3M | ||
| Q2 25 | $-1.2M | $79.3M | ||
| Q1 25 | $-101.2M | $72.6M | ||
| Q4 24 | $-864.6M | $57.7M | ||
| Q3 24 | $-38.2M | $65.5M | ||
| Q2 24 | $-15.8M | $66.6M | ||
| Q1 24 | $-110.2M | $56.8M |
毛利率EXASIESC
| Q4 25 | 70.1% | 25.3% | ||
| Q3 25 | 68.6% | 26.0% | ||
| Q2 25 | 69.3% | 26.9% | ||
| Q1 25 | 70.8% | 25.0% | ||
| Q4 24 | 69.0% | 23.8% | ||
| Q3 24 | 69.4% | 24.0% | ||
| Q2 24 | 69.8% | 25.3% | ||
| Q1 24 | 70.0% | 24.3% |
营业利润率EXASIESC
| Q4 25 | -9.4% | 11.2% | ||
| Q3 25 | -3.0% | 11.6% | ||
| Q2 25 | -0.3% | 12.6% | ||
| Q1 25 | -13.6% | 11.1% | ||
| Q4 24 | -122.8% | 10.0% | ||
| Q3 24 | -5.6% | 9.7% | ||
| Q2 24 | -3.8% | 11.7% | ||
| Q1 24 | -16.7% | 11.0% |
净利率EXASIESC
| Q4 25 | -9.8% | 10.5% | ||
| Q3 25 | -2.3% | 11.4% | ||
| Q2 25 | -0.1% | 8.9% | ||
| Q1 25 | -14.3% | 8.7% | ||
| Q4 24 | -121.2% | 7.7% | ||
| Q3 24 | -5.4% | 8.4% | ||
| Q2 24 | -2.3% | 8.7% | ||
| Q1 24 | -17.3% | 8.0% |
每股收益（稀释后）EXASIESC
| Q4 25 | $-0.45 | $4.51 | ||
| Q3 25 | $-0.10 | $4.99 | ||
| Q2 25 | $-0.01 | $3.81 | ||
| Q1 25 | $-0.54 | $3.50 | ||
| Q4 24 | $-4.69 | $2.72 | ||
| Q3 24 | $-0.21 | $3.06 | ||
| Q2 24 | $-0.09 | $2.67 | ||
| Q1 24 | $-0.60 | $2.29 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $964.7M | $258.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.4B | $961.1M |
| 总资产 | $5.9B | $1.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资EXASIESC
| Q4 25 | $964.7M | $258.7M | ||
| Q3 25 | $1.0B | $231.8M | ||
| Q2 25 | $858.4M | $168.3M | ||
| Q1 25 | $786.2M | $88.3M | ||
| Q4 24 | $1.0B | $112.0M | ||
| Q3 24 | $1.0B | $135.8M | ||
| Q2 24 | $946.8M | $44.9M | ||
| Q1 24 | $652.1M | $106.0M |
股东权益EXASIESC
| Q4 25 | $2.4B | $961.1M | ||
| Q3 25 | $2.5B | $884.0M | ||
| Q2 25 | $2.5B | $781.4M | ||
| Q1 25 | $2.4B | $705.8M | ||
| Q4 24 | $2.4B | $652.4M | ||
| Q3 24 | $3.2B | $611.1M | ||
| Q2 24 | $3.2B | $567.5M | ||
| Q1 24 | $3.1B | $534.8M |
总资产EXASIESC
| Q4 25 | $5.9B | $1.7B | ||
| Q3 25 | $5.9B | $1.6B | ||
| Q2 25 | $5.8B | $1.5B | ||
| Q1 25 | $5.7B | $1.4B | ||
| Q4 24 | $5.9B | $1.3B | ||
| Q3 24 | $6.7B | $1.2B | ||
| Q2 24 | $6.7B | $1.2B | ||
| Q1 24 | $6.4B | $1.1B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $151.7M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $120.4M | $-18.9M |
| 自由现金流率自由现金流/营收 | 13.7% | -2.2% |
| 资本支出强度资本支出/营收 | 3.6% | 5.3% |
| 现金转化率经营现金流/净利润 | — | 0.30× |
| 过去12个月自由现金流最近4个季度 | $356.8M | $175.9M |
8季度趋势，按日历期对齐
经营现金流EXASIESC
| Q4 25 | $151.7M | $27.7M | ||
| Q3 25 | $219.9M | $132.0M | ||
| Q2 25 | $89.0M | $92.0M | ||
| Q1 25 | $30.8M | $24.8M | ||
| Q4 24 | $47.1M | $37.3M | ||
| Q3 24 | $138.7M | $92.8M | ||
| Q2 24 | $107.1M | $82.9M | ||
| Q1 24 | $-82.3M | $33.7M |
自由现金流EXASIESC
| Q4 25 | $120.4M | $-18.9M | ||
| Q3 25 | $190.0M | $112.0M | ||
| Q2 25 | $46.7M | $74.8M | ||
| Q1 25 | $-365.0K | $7.9M | ||
| Q4 24 | $10.7M | $24.1M | ||
| Q3 24 | $112.6M | $78.5M | ||
| Q2 24 | $71.2M | $65.4M | ||
| Q1 24 | $-120.0M | $26.9M |
自由现金流率EXASIESC
| Q4 25 | 13.7% | -2.2% | ||
| Q3 25 | 22.3% | 12.5% | ||
| Q2 25 | 5.8% | 8.4% | ||
| Q1 25 | -0.1% | 0.9% | ||
| Q4 24 | 1.5% | 3.2% | ||
| Q3 24 | 15.9% | 10.1% | ||
| Q2 24 | 10.2% | 8.5% | ||
| Q1 24 | -18.8% | 3.8% |
资本支出强度EXASIESC
| Q4 25 | 3.6% | 5.3% | ||
| Q3 25 | 3.5% | 2.2% | ||
| Q2 25 | 5.2% | 1.9% | ||
| Q1 25 | 4.4% | 2.0% | ||
| Q4 24 | 5.1% | 1.8% | ||
| Q3 24 | 3.7% | 1.8% | ||
| Q2 24 | 5.1% | 2.3% | ||
| Q1 24 | 5.9% | 1.0% |
现金转化率EXASIESC
| Q4 25 | — | 0.30× | ||
| Q3 25 | — | 1.29× | ||
| Q2 25 | — | 1.16× | ||
| Q1 25 | — | 0.34× | ||
| Q4 24 | — | 0.65× | ||
| Q3 24 | — | 1.42× | ||
| Q2 24 | — | 1.24× | ||
| Q1 24 | — | 0.59× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EXAS
| Screening | $695.1M | 79% |
| Precision Oncology | $183.2M | 21% |
IESC
| Communications | $351.9M | 40% |
| Single Family Electrical Contracts | $137.0M | 16% |
| Custom Engineered Solutions | $116.0M | 13% |
| Commercialand Industrial | $94.8M | 11% |
| Single Family Contracts Plumbing HVAC | $82.9M | 10% |
| Multi Familyand Other | $64.2M | 7% |
| Industrial Services | $24.2M | 3% |
